The latest update is out from Urogen Pharma (URGN).
UroGen Pharma Ltd. will be presenting at the TD Cowen 44th Annual Health Care Conference on March 4, 2024, showcasing information that is crucial for investors tracking the company’s progress. The presentation details, though important, are not considered legally filed under the Securities Exchange Act, nor are they automatically integrated into the company’s formal regulatory filings, but may be referenced explicitly in future documents.
Learn more about URGN stock on TipRanks’ Stock Analysis page.
